XML 36 R44.htm IDEA: XBRL DOCUMENT v2.4.0.8
Fair Value Measurements Fair value hierarchy the Company’s financial assets and liabilities (Details) (USD $)
9 Months Ended
Sep. 30, 2014
May 08, 2014
Dec. 31, 2013
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Acquisition-related contingent consideration $ 22,430,000 $ 11,900,000 $ 9,450,000
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High   90,000,000  
Business Combination, Consideration Transferred, Liabilities Incurred 11,890,000    
Available-for-sale Securities 665,100   0
Marketable securities 665,112   0
Warrant Derivative Liabilities 0   23,200
Accrued Liabilities and Other Liabilities 22,430,000   9,473,200
Business Combination, Liabilities Arising from Contingencies, Amount Recognized 12,400,000    
Fair Value, Inputs, Level 1 [Member]
     
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Available-for-sale Securities 0   0
Marketable securities 0   0
Warrant Derivative Liabilities 0   0
Contingent Consideration Classified as Equity, Fair Value Disclosure 0   0
Accrued Liabilities and Other Liabilities 0   0
Fair Value, Inputs, Level 2 [Member]
     
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Available-for-sale Securities 665,100   0
Marketable securities 665,100   0
Warrant Derivative Liabilities 0   0
Contingent Consideration Classified as Equity, Fair Value Disclosure 0   0
Accrued Liabilities and Other Liabilities 0   0
Fair Value, Inputs, Level 3 [Member]
     
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Available-for-sale Securities 0   0
Marketable securities 0   0
Warrant Derivative Liabilities 0   23,200
Contingent Consideration Classified as Equity, Fair Value Disclosure 22,430,000   9,450,000
Accrued Liabilities and Other Liabilities 22,430,000   9,473,200
Assets, Total [Member]
     
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Marketable securities 665,100   0
Contingent Consideration Classified as Equity [Member]
     
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Acquisition-related contingent consideration 22,430,000   9,450,000
Business Combination, Consideration Transferred, Liabilities Incurred 11,890,000    
Amorcyte, LLC [Member]
     
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Acquisition-related contingent consideration 10,100,000   9,500,000
Warrants
     
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Warrant Derivative Liabilities 0   23,200
Contingent Consideration Classified as Equity [Member]
     
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Contingent Consideration Classified as Equity, Fair Value Disclosure $ 22,430,000   $ 9,450,000